Trademark Overview
On Tuesday, December 31, 2024, a trademark application was filed for NEUROLAMBDA THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the NEUROLAMBDA THERAPEUTICS trademark a serial number of 98931119. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Tuesday, December 31, 2024. This trademark is owned by NeuroLambda Therapeutics, Inc.. The NEUROLAMBDA THERAPEUTICS trademark is filed in the Chemical Products, Pharmaceutical Products, and Computer & Software Services & Scientific Services categories with the following description:
Pharmaceutical preparations for the prevention and treatment of diseases and disorders, namely, neurological disorders with brain-penetrant small molecules as well as inflammatory diseases and metabolic disorders.
Chemicals and biological preparations for use in the biological, biotechnological, medical and pharmaceutical industries; medicinal and biological preparations for research, laboratory, and medical laboratory use, namely, preparations used in the manufacture of pharmaceuticals for treating neurological disorders with brain-penetrant small molecules as well as inflammatory diseases and metabolic disorders
Research and development in the fields of therapeutics, pharmaceutical and biotechnology; pharmaceutical research and development services; research and development of therapeutics and pharmaceuticals; consulting services in the field of pharmaceuticals, namely, pharmaceutical and therapeutic research; pharmaceutical research for small molecule drug discovery and development; medical research; providing medical and scientific research information in the fields of therapeutics, biologicals and pharmaceuticals